Séminaire du Pr Paul Van Tassel, lauréat de la Commission Franco-Américaine Fulbright ••• 6 juin 2019

From Life Sciences UPSaclay

Le Professeur Paul Van Tassel de l'Université de Yale aux USA est en séjour pour trois mois à l'Institut Galien Paris-Sud sur un financement Fulbrigth.

Il donnera un séminaire le 6 juin à 11h à la Faculté de Pharmacie de l'UPSud (Salle AB 19/5, Châtenay-Malabry) sur le thème de : "Polyelectrolyte Nanofilms as Biomolecular Delivery Systems".

Paul Van Tassel is Professor of Chemical and Environmental Engineering at Yale University. His research interests include colloidal/interfacial phenomena, polymers, biomaterials, adsorption, molecular computer simulation, and statistical mechanics. He is a National Science Foundation CAREER Awardee, a National Academy of Engineering Frontiers of Engineering Invitee, and a Connecticut Academy of Science and Engineering Elected Member. He has published over 80 peer-reviewed articles, and has been awarded grants from the National Science Foundation, the National Institutes of Health, the American Chemical Society, the Unilever Corporation, the Fulbright Foundation, and the Burroughs-Wellcome Fund. Prof. Van Tassel has held several invited posts in France: Université Pierre et Marie Curie (Paris, 1993-1996), Université Louis Pasteur (Strasbourg, 2006), and Université de Cergy-Pontoise (Paris, 2009 and 2016-17). He holds a BA in Chemistry and Mathematics from Saint Olaf College and a PhD in Chemical Engineering from the University of Minnesota, and lives in New Haven, CT with his wife and three children.


Research will be conducted toward the chemical conjugation of a pharmaceutically active molecule to a charged polymer (a polyelectrolyte “prodrug”), and the subsequent complexation of this charged species with an oppositely charged polymer, so as to form a therapeutically active “nanocarrier” particle. By combining the electrostatic macromolecular assembly expertise of Prof. Van Tassel with the nanocarrier and prodrug expertise of the Institut Galien, a new US-France scientific collaboration is envisioned toward novel drug delivery approaches for challenging diseases, such as cancer.


Contact : elias.fattal @ u-psud.fr